WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ:ALTH), a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics, today announced that the Company will report its financial results for the second quarter ended June 30, 2010 on Wednesday, July 28, 2010 before the financial markets open. Following the release of the financial results, Allos management will provide a corporate update and review of the second quarter 2010 results via audio webcast conference call on Wednesday, July 28, 2010, at 8:30 a.m. Eastern Time (ET).
